Posts Tagged ‘importation’
“Reducing costs requires more than all of this non–value-added activity,” Expert Says
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
[...]July 29, 2020 video: Importation Executive Order Explainer
On July 24, 2020, the White House issued an executive order to implement three approaches to foreign drug importation, all of which involve dipping into other countries’ drug supplies and putting them in U.S. medicine cabinets. Watch this week’s video to learn more.
[...]July 15, 2020 video: The Slow Boat to Justice–Prosecuting Foreign Drug Counterfeiters
Importing medicine from Canada is more dangerous than it looks because it is so difficult to prosecute fake or substandard drug sellers. Legislators and their consultants make it sound as if holding a foreign vendor accountable will be easy, but history has shown that the U.S. federal government, with all of its agreements, power, and resources, still struggles to bring criminals to justice.
[...]President of the International AntiCounterfeiting Coalition Warns That Importation Will Open the Door to Drug Counterfeiters
In the midst of a nationwide epidemic of opioid addiction fueled by illicit smuggling of drugs from overseas, and coming on the heels of a year in which U.S. Customs and Border Protection seized over $73 million worth of counterfeit medicines at our nation’s ports, some members of Congress have suggested a novel approach to these growing threats: “opening the floodgates.”
[...]Op-Ed: Why Drug Importation Is Flawed Policy
Mike Leavitt | March 20, 2017 With the issue of prescription drug importation being debated on Capitol Hill again, mark me in the skeptical camp. As a matter of safety and practical policymaking, drug importation simply doesn’t work. It is not by happenstance that our country has the world’s safest drug supply. Counterfeit medicines are proliferating…
[...]In 2013, Maine became the 1st state in the country to enact a “drug importation ordinance.”
By February of 2015 the law had been thrown out, but only after the President of the Maine Pharmacy Association experienced first hand what patients can be exposed to when buying drugs from a Canadian online pharmacy. On June 27, 2013, the Maine Legislature passed LD 171, the Act to Facilitate Personal Importation of Prescription…
[...]No Such Thing as a “Safe Country” for Drug Importation
With talks about drug importation continuing in Congress, drug importation supporters argue that if the United States allows importation only from “safe countries,” such as Canada and the United Kingdom, than most of drug safety concerns would be eliminated. However, when it comes to drug importation, there is no such thing as a “safe” country.
[...]Inside the World of Counterfeit Drugs
Part 3: Implications for the U.S. and the Drug Importation Debate – As the debate surrounding the possible ban on the repackaging of medicines in Europe simmers to a boil, here in the United States the potentially dangerous practice of ordering prescription medicines via the Internet is mushrooming. Enticed by the promise of cheaper drugs and convenience by buying online, patients are largely unaware of the risks that come with online pharmacies. These risks can range from receiving products with too much, too little or no active ingredients, to being exposed to counterfeit products, which in some rare cases have been found to contain rat poison, boric acid and even inkjet cartridges!
[...]Congress on the Right Road to Stop Drug Counterfeiters
Earlier this year, Reps. John D. Dingell (D-MI 15), Frank Pallone, Jr. (D-NJ 06) and Bart Stupak (D-MI 01) introduced the Food and Drug Administration Globalization Act of 2009 (H.R.759). This legislation indicates that Congress is fbeginning an important journey to address several real threats that substandard and counterfeit drugs pose to the pharmaceutical supply chain.
[...]Letter to President Barack Obama
April 8, 2009 President Barack Obama1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President, On behalf of the Partnership for Safe Medicines (PSM), a group of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines and dedicated to the safety of the drug supply, I would like…
[...]